Shinji Oyama

Principal Scientist @Adaptimmune

Medford, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2023 — Present

Principal Scientist @Adaptimmune

View department →

Cambridge, MA, US

Leading Analytical Development efforts on multiple projects and overseeing all analytical activities for Process & Analytical Development (PAD) group • Analytical Lead on CMC team on multiple projects including a phase 3 clinical project o Re-establish clinical readiness on a tight timeline on a previously discontinued program o Lead PAD readiness efforts to support clinical readiness - Re-established clinical analytical methods in PAD group, develop Fit for Purpose strategy for assays, cell lines, and controls o Collaborate with CRO for clinical readiness -Develop strategy and transfer re-established Analytical methods, cell lines, and controls to CRO for Phase 3 clinical use o Perform gap and risk assessments, formulate and oversee analytical work packages o Oversee or Author any ROPs/regulatory writings• Support and train junior scientists

EDUCATION

2005 — 2010

Harvard University Extension School

Master of Arts - MA, Biology

1995 — 1999

Tufts University

BS, Biology/History

SKILLS

Cell CultureLifesciencesGel ElectrophoresisCell CultureImmunologyAssay DevelopmentTransfectionHigh-Performance Liquid Chromatography (Hplc)Molecular CloningBiochemistryDna SequencingLife SciencesTeam LeadershipImmunohistochemistryElisaProblem SolvingAnalytical BiochemistryPolymerase Chain Reaction (Pcr)Statistical Data AnalysisDrug DevelopmentFlow CytometryTeamworkAnalytical SkillsGeneticsHigh Throughput ScreeningDrug DiscoveryMolecular & Cellular BiologySds-PageMolecular BiologyData AnalysisData CollectionResearchWestern BlottingCell BiologyIn VitroCellBiotechnologyProtein PurificationCoachingData Analytics

ABOUT SHINJI OYAMA

A scientist with 24 years of experience with a diverse knowledge of various technologies, areas of research, and drug development. Most recently, an Analytical Development Lead at a lentiviral gene therapy company, focusing on Phase 3 readiness. Demonstrated ability to build and mentor scientific teams. A flexible, dependable team player valued for diversity of knowledge and ability to learn swiftly. Demonstrated ability to meet or exceed aggressive deadlines and effectively take on new and multiple roles in dynamic R&D environments.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Shinji Oyama — Principal Scientist at Adaptimmune in Medford, MA, US | Unifers